Teva Pharmaceutical Industries
TEVA
$7.23
Share price
0.42%
Change (1 day)
-24.05%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - P/B ratio
P/B ratio as of June 2023 : 0.9477
According to Teva Pharmaceutical Industries's latest financial reports the company has a price-to-book ratio of 0.9477.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Teva Pharmaceutical Industries - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 1.17 | 48.32% |
| 2021-12-31 | 0.7858 | -16.53% |
| 2020-12-31 | 0.9414 | 31.42% |
| 2019-12-31 | 0.7163 | -33.31% |
| 2018-12-31 | 1.07 | 4.49% |
| 2017-12-31 | 1.03 | -2.23% |
| 2016-12-31 | 1.05 | -46.82% |
| 2015-12-31 | 1.98 | -4.91% |
| 2014-12-31 | 2.08 | 39.29% |
| 2013-12-31 | 1.49 | 7.19% |
| 2012-12-31 | 1.39 | -12.68% |
| 2011-12-31 | 1.60 | -24.99% |
| 2010-12-31 | 2.13 | -17.67% |
| 2009-12-31 | 2.58 | 11.69% |
| 2008-12-31 | 2.31 | -15.27% |
| 2007-12-31 | 2.73 | 23.77% |
| 2006-12-31 | 2.21 | -52.03% |
| 2005-12-31 | 4.60 | 32.61% |
| 2004-12-31 | 3.47 | -27.44% |
| 2003-12-31 | 4.78 | -12.25% |
| 2002-12-31 | 5.44 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 4.02 | 324.23% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.26 | 138.17% | 🇺🇸 USA |
 Sanofi SNY | 1.58 | 67.04% | 🇫🇷 France |
 Merck MRK | 6.20 | 554.11% | 🇺🇸 USA |
 AstraZeneca AZN | 6.28 | 562.99% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 4.99 | 426.99% | 🇬🇧 UK |
 Dr. Reddy's RDY | 3.73 | 293.14% | 🇮🇳 India |